VanEck Gold Miners ETF vs DENTSPLY SIRONA Inc — how do they compare? VanEck Gold Miners ETF trades at $71.97, while DENTSPLY SIRONA Inc trades at $13.86 (market cap $2.68B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while VanEck Gold Miners ETF pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, VanEck Gold Miners ETF nearer its low. Which is the better fit depends on your goals.
| GDX | XRAY | |
|---|---|---|
52-Week High | $115.84 | $16.85 |
52-Week Low | $51.15 | $9.64 |
Market Cap | — | $2.68B |
Sector | — | Health |
Enterprise Value | — | $4.83B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
The VanEck Gold Miners ETF (GDX) is trading at $71.97, down 3.89% over the past 24 hours, with a strong bearish technical signal from moving averages. The fund provides exposure to senior gold mining equities, which are currently trading at historically low valuations according to recent analysis, with forward P/E and EV/EBITDA multiples at five-year lows. Recent news highlights ongoing comparisons with lower-fee bullion ETFs and debates about the optimal vehicle for gold exposure.
The outlook presents a dichotomy: attractive valuation metrics and record free cash flow yields suggest potential upside if gold prices rally, while technical weakness and competition from more efficient gold ETFs pose significant risks. A re-rating to historical valuation norms could imply 20% upside, but the fund's performance remains heavily dependent on gold price movements and mining company operational execution.
Dentsply Sirona (XRAY) trades at $12.70, down 0.63% with bearish profitability metrics including negative net income margin and ROE. The stock shows mixed technical signals with bullish moving averages but overbought RSI levels. Recent earnings have consistently missed expectations, though the company maintains a 48.93% gross margin and is expanding its US distribution network with new partnerships and AI-enabled product launches.
While analyst consensus leans Hold with a $13.33 price target, the stock faces significant fundamental challenges including declining revenue, negative earnings, and rising debt-to-asset ratios. Near-term catalysts include the Q2 2026 earnings report and continued execution of the Return-to-Growth plan, but investors should weigh the high valuation multiples against persistent profitability concerns.
Trailing returns across standard periods
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →